Aspira women's health to present at the h.c. wainwright 26th annual global investment conference

Austin, texas, sept. 06, 2024 (globe newswire) -- aspira women's health inc. (“aspira”) (nasdaq: awh), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that nicole sandford, ceo of aspira women's health will present at the h.c. wainwright 26th annual global investment conference being held september 9-11, 2024 at the lotte new york palace hotel in new york, ny.
AWH Ratings Summary
AWH Quant Ranking